These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 26510692)
1. Implication of thymoquinone as a remedy for polycystic ovary in rat. Arif M; Thakur SC; Datta K Pharm Biol; 2016; 54(4):674-85. PubMed ID: 26510692 [TBL] [Abstract][Full Text] [Related]
2. Disrupted hyaluronan binding protein 1 (HABP1) expression: one of the key mediator for ovarian dysfunction in polycystic ovary rat. Arif M; Thakur SC; Datta K Mol Cell Biochem; 2015 Jan; 398(1-2):233-44. PubMed ID: 25300617 [TBL] [Abstract][Full Text] [Related]
3. Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis. Sethi G; Ahn KS; Aggarwal BB Mol Cancer Res; 2008 Jun; 6(6):1059-70. PubMed ID: 18567808 [TBL] [Abstract][Full Text] [Related]
4. Upsurge in autophagy, associated with mifepristone-treated polycystic ovarian condition, is reversed upon thymoquinone treatment. Saha P; Kumar S; Datta K; Tyagi RK J Steroid Biochem Mol Biol; 2021 Apr; 208():105823. PubMed ID: 33484844 [TBL] [Abstract][Full Text] [Related]
5. Thymoquinone attenuates proinflammatory responses in lipopolysaccharide-activated mast cells by modulating NF-kappaB nuclear transactivation. El Gazzar MA; El Mezayen R; Nicolls MR; Dreskin SC Biochim Biophys Acta; 2007 Apr; 1770(4):556-64. PubMed ID: 17292554 [TBL] [Abstract][Full Text] [Related]
6. Microenvironmental effects limit efficacy of thymoquinone treatment in a mouse model of ovarian cancer. Wilson AJ; Saskowski J; Barham W; Khabele D; Yull F Mol Cancer; 2015 Nov; 14():192. PubMed ID: 26552746 [TBL] [Abstract][Full Text] [Related]
7. Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer. Wilson AJ; Saskowski J; Barham W; Yull F; Khabele D J Ovarian Res; 2015 Jul; 8():46. PubMed ID: 26215403 [TBL] [Abstract][Full Text] [Related]
8. Elucidation of molecular mechanisms underlying the protective effects of thymoquinone against rheumatoid arthritis. Vaillancourt F; Silva P; Shi Q; Fahmi H; Fernandes JC; Benderdour M J Cell Biochem; 2011 Jan; 112(1):107-17. PubMed ID: 20872780 [TBL] [Abstract][Full Text] [Related]
10. Anti-fibrotic effect of thymoquinone on hepatic stellate cells. Ghazwani M; Zhang Y; Gao X; Fan J; Li J; Li S Phytomedicine; 2014 Feb; 21(3):254-60. PubMed ID: 24182989 [TBL] [Abstract][Full Text] [Related]
11. Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling. Thummuri D; Jeengar MK; Shrivastava S; Nemani H; Ramavat RN; Chaudhari P; Naidu VG Pharmacol Res; 2015 Sep; 99():63-73. PubMed ID: 26022736 [TBL] [Abstract][Full Text] [Related]
12. Thymoquinone inhibits phorbol ester-induced activation of NF-κB and expression of COX-2, and induces expression of cytoprotective enzymes in mouse skin in vivo. Kundu JK; Liu L; Shin JW; Surh YJ Biochem Biophys Res Commun; 2013 Sep; 438(4):721-7. PubMed ID: 23911786 [TBL] [Abstract][Full Text] [Related]
13. Protective Effects of Thymoquinone Against Convulsant Activity Induced by Lithium-Pilocarpine in a model of Status Epilepticus. Shao Y; Feng Y; Xie Y; Luo Q; Chen L; Li B; Chen Y Neurochem Res; 2016 Dec; 41(12):3399-3406. PubMed ID: 27752802 [TBL] [Abstract][Full Text] [Related]
14. Thymoquinone attenuates monocrotaline-induced pulmonary artery hypertension via inhibiting pulmonary arterial remodeling in rats. Zhu N; Zhao X; Xiang Y; Ye S; Huang J; Hu W; Lv L; Zeng C Int J Cardiol; 2016 Oct; 221():587-96. PubMed ID: 27420584 [TBL] [Abstract][Full Text] [Related]
15. Thymoquinone from nutraceutical black cumin oil activates Neu4 sialidase in live macrophage, dendritic, and normal and type I sialidosis human fibroblast cells via GPCR Galphai proteins and matrix metalloproteinase-9. Finlay TM; Jayanth P; Amith SR; Gilmour A; Guzzo C; Gee K; Beyaert R; Szewczuk MR Glycoconj J; 2010 Apr; 27(3):329-48. PubMed ID: 20213245 [TBL] [Abstract][Full Text] [Related]
16. Dual targeting of TNF-α and free radical toxic stress as a promising strategy to manage experimental polycystic ovary. Rezvanfar MA; Saeedi S; Mansoori P; Saadat S; Goosheh M; Shojaei Saadi HA; Baeeri M; Abdollahi M Pharm Biol; 2016; 54(1):80-90. PubMed ID: 25955958 [TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effects of thymoquinone and its protective effects against several diseases. Kohandel Z; Farkhondeh T; Aschner M; Samarghandian S Biomed Pharmacother; 2021 Jun; 138():111492. PubMed ID: 33743334 [TBL] [Abstract][Full Text] [Related]
18. Thymoquinone blocks lung injury and fibrosis by attenuating bleomycin-induced oxidative stress and activation of nuclear factor Kappa-B in rats. El-Khouly D; El-Bakly WM; Awad AS; El-Mesallamy HO; El-Demerdash E Toxicology; 2012 Dec; 302(2-3):106-13. PubMed ID: 22982510 [TBL] [Abstract][Full Text] [Related]
19. Thymoquinone reduces intracytoplasmic oxidative stress and improves epigenetic modification in polycystic ovary syndrome mice oocytes, during in-vitro maturation. Eini F; Bidadkosh A; Nazarian H; Piryaei A; Ghaffari Novin M; Joharchi K Mol Reprod Dev; 2019 Aug; 86(8):1053-1066. PubMed ID: 31209968 [TBL] [Abstract][Full Text] [Related]
20. Thymoquinone inhibits matrix metalloproteinase expression in rabbit chondrocytes and cartilage in experimental osteoarthritis. Chen WP; Tang JL; Bao JP; Wu LD Exp Biol Med (Maywood); 2010 Dec; 235(12):1425-31. PubMed ID: 21127340 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]